CRIS Current Research Information System

DE SANTIS, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 392
EU - Europa 280
AS - Asia 49
AF - Africa 46
SA - Sud America 3
Totale 770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 390
IT - Italia 91
SE - Svezia 49
GB - Regno Unito 43
IE - Irlanda 35
DE - Germania 31
TG - Togo 29
IN - India 20
CN - Cina 14
NG - Nigeria 10
JO - Giordania 8
CH - Svizzera 5
FR - Francia 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
PL - Polonia 4
RU - Federazione Russa 4
FI - Finlandia 3
ZA - Sudafrica 3
CA - Canada 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
TR - Turchia 2
UA - Ucraina 2
CL - Cile 1
HK - Hong Kong 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
SG - Singapore 1
Totale 770
Salva come PNG Salva come JPEG
Città #
Chandler 100
Southend 40
Dublin 35
Bologna 30
Lomé 29
Fairfield 20
Princeton 20
Redmond 20
Ashburn 13
Wilmington 12
Abeokuta 10
Woodbridge 10
Berlin 9
Houston 9
Turin 9
Amman 8
Cambridge 7
Seattle 7
New York 6
San Diego 6
Bern 5
Boydton 5
Rome 5
Abidjan 4
Ann Arbor 4
Dehradun 4
Des Moines 4
Florence 4
Sofia 4
Warsaw 4
Beijing 3
Bremen 3
Brescia 3
Castel Madama 3
Medford 3
Saint Petersburg 3
Shenyang 3
Westminster 3
Zhengzhou 3
Ankara 2
Cervia 2
Fano 2
Francofonte 2
Frederiksberg 2
Grand Forks 2
Guayaquil 2
Helsinki 2
Imola 2
Latina 2
Malvern 2
Miradolo Terme 2
Mountain View 2
Norwalk 2
Olalla 2
Padova 2
Siena 2
Toronto 2
Bangalore 1
Bühl 1
Canzo 1
Cesena 1
Fremont 1
Hebei 1
Lanzhou 1
Lappeenranta 1
Lissone 1
London 1
Los Angeles 1
Nanchang 1
Nanjing 1
North Bergen 1
Reggio Emilia 1
San Francisco 1
Seoul 1
Singapore 1
Tianjin 1
Totale 525
Salva come PNG Salva come JPEG
Nome #
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 112
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 99
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 87
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 72
Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells 71
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells 66
Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy 63
The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities 59
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia 39
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia 34
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort? 34
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 25
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors 19
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis 15
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 10
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights 9
Totale 814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 1 4
2019/202054 10 3 0 3 7 3 7 4 5 4 4 4
2020/202172 7 2 0 0 1 2 9 21 9 3 7 11
2021/2022172 3 0 5 4 20 12 2 15 11 15 50 35
2022/2023376 42 62 9 31 39 21 19 15 71 13 42 12
2023/2024122 1 25 13 20 12 13 5 17 3 9 4 0
Totale 814